| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 16766468 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 320 journal articles in the PubMed database | Email to a friend | | |
| Mystakidou K, Katsouda E, Parpa E, et al.
Oral transmucosal fentanyl citrate: overview of pharmacological and clinical characteristics. [Journal Article]
Drug Deliv 2006 Jul-Aug; 13(4):269-76.
Abstract | Full Citation | Find Related Articles | | Mystakidou K, Katsouda E, Parpa E, et al.
Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: an overview of its pharmacological and clinical characteristics. [Journal Article]
J Opioid Manag 2005 Mar-Apr; 1(1):36-40.
Abstract | Full Citation | | Mystakidou K, Katsouda E, Parpa E, et al.
Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: an overview of its pharmacological and clinical characteristics. [Journal Article, Review]
Am J Hosp Palliat Care 2005 May-Jun; 22(3):228-32.
Abstract | Full Citation | Find Related Articles | | Borgbjerg FM, Rosenberg J
[Oral transmucosal fentanyl citrate (OTFC) in the treatment of breakthrough pain] [Journal Article]
Ugeskr Laeger 2000 Sep 25; 162(39):5237-40.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Portenoy RK, Payne R, Coluzzi P, et al.
Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Pain 1999 Feb; 79(2-3):303-12.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Mystakidou K, Tsilika E, Tsiatas M, et al.
Oral transmucosal fentanyl citrate in cancer pain management: a practical application of nanotechnology. [Journal Article]
Int J Nanomedicine 2007; 2(1):49-54.
Abstract | Full Citation | Find Related Articles | | Darwish M, Tempero K, Kirby M, et al.
Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1080 pg versus Oral transmucosal fentanyl citrate 1600 pg and dose proportionality of FEBT 270 to 1300 mug: A single-dose, randomized, open-label, three-period study in healthy adult volunteers. [Journal Article]
Clin Ther 2006 May; 28(5):715-24.
Abstract | Full Citation | | Messina J, Darwish M, Fine PG
Fentanyl buccal tablet. [Journal Article]
Drugs Today (Barc) 2008 Jan; 44(1):41-54.
Abstract | Full Citation | Find Related Articles | | Rees E
The role of oral transmucosal fetanyl citrate in the management of breakthrough cancer pain. [Journal Article, Review]
Int J Palliat Nurs 2002 Jun; 8(6):304-8.
Abstract | Full Citation | Find Related Articles |   |
|
| |
Advertise on this site.
|
